<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/css" href="http://owiki.kmu.edu.tw/skins/common/feed.css?63"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
	<channel>
		<title>Alport’s syndrome - 修訂歷史</title>
		<link>http://owiki.kmu.edu.tw/index.php?title=Alport%E2%80%99s_syndrome&amp;action=history</link>
		<description>本站上此頁的修訂歷史</description>
		<language>zh-tw</language>
		<generator>MediaWiki 1.10.1</generator>
		<lastBuildDate>Sat, 04 Apr 2026 17:35:27 GMT</lastBuildDate>
		<item>
			<title>Guhjy在2018年3月14日 (三) 01:57</title>
			<link>http://owiki.kmu.edu.tw/index.php?title=Alport%E2%80%99s_syndrome&amp;diff=24445&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table border='0' width='98%' cellpadding='0' cellspacing='4' style=&quot;background-color: white;&quot;&gt;
			&lt;tr&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;←上一修訂&lt;/td&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;在2018年3月14日 (三) 01:57所做的修訂版本&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第1行：&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第1行：&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*''X-linked'' inheritance (85%)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*''X-linked'' inheritance (85%)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;**Genetic defect in &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;@@color(red):''&lt;/del&gt;&amp;amp;alpha;5 chain of type IV collagen&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;''@@&lt;/del&gt;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;**Genetic defect in &amp;amp;alpha;5 chain of type IV collagen&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Chromosome Xq22–24&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Chromosome Xq22–24&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Mild in female carriers&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Mild in female carriers&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Wed, 14 Mar 2018 01:57:38 GMT</pubDate>			<dc:creator>Guhjy</dc:creator>			<comments>http://owiki.kmu.edu.tw/index.php/Talk:Alport%E2%80%99s_syndrome</comments>		</item>
		<item>
			<title>Guhjy在2018年3月14日 (三) 01:57</title>
			<link>http://owiki.kmu.edu.tw/index.php?title=Alport%E2%80%99s_syndrome&amp;diff=24444&amp;oldid=prev</link>
			<description>&lt;p&gt;&lt;/p&gt;

			&lt;table border='0' width='98%' cellpadding='0' cellspacing='4' style=&quot;background-color: white;&quot;&gt;
			&lt;tr&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;←上一修訂&lt;/td&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;在2018年3月14日 (三) 01:57所做的修訂版本&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第18行：&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第18行：&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***EM: Thin GBM &amp;amp;rarr; multilamellations surrounding lucent areas that often contain granules of varying density (split basement membrane)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;***EM: Thin GBM &amp;amp;rarr; multilamellations surrounding lucent areas that often contain granules of varying density (split basement membrane)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Renal transplantation&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Renal transplantation&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;**&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;@@color(red):''~&lt;/del&gt;Anti-GBM antibodies&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;'' &lt;/del&gt;directed toward the collagen epitopes absent in their native kidneys&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;@@&lt;/del&gt;, but overt Goodpasture's syndrome is uncommon and graft survival is good&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;**Anti-GBM antibodies directed toward the collagen epitopes absent in their native kidneys, but overt Goodpasture's syndrome is uncommon and graft survival is good&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</description>
			<pubDate>Wed, 14 Mar 2018 01:57:10 GMT</pubDate>			<dc:creator>Guhjy</dc:creator>			<comments>http://owiki.kmu.edu.tw/index.php/Talk:Alport%E2%80%99s_syndrome</comments>		</item>
		<item>
			<title>Guhjy: 新頁面: *''X-linked'' inheritance (85%) **Genetic defect in @@color(red):''&amp;alpha;5 chain of type IV collagen''@@ **Chromosome Xq22–24 **Mild in female carriers *AR (15%): &amp;alpha;3(IV) or &amp;alph...</title>
			<link>http://owiki.kmu.edu.tw/index.php?title=Alport%E2%80%99s_syndrome&amp;diff=24443&amp;oldid=prev</link>
			<description>&lt;p&gt;新頁面: *''X-linked'' inheritance (85%) **Genetic defect in @@color(red):''&amp;amp;alpha;5 chain of type IV collagen''@@ **Chromosome Xq22–24 **Mild in female carriers *AR (15%): &amp;amp;alpha;3(IV) or &amp;amp;alph...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新頁面&lt;/b&gt;&lt;/p&gt;&lt;div&gt;*''X-linked'' inheritance (85%)&lt;br /&gt;
**Genetic defect in @@color(red):''&amp;amp;alpha;5 chain of type IV collagen''@@&lt;br /&gt;
**Chromosome Xq22–24&lt;br /&gt;
**Mild in female carriers&lt;br /&gt;
*AR (15%): &amp;amp;alpha;3(IV) or &amp;amp;alpha;4(IV) collagen (chromosome 2q35–37)&lt;br /&gt;
*AD (rare): &amp;amp;alpha;3(IV) or &amp;amp;alpha;4(IV) chains&lt;br /&gt;
**AD &amp;amp; AR: Male &amp;amp; females have equal severity&lt;br /&gt;
*Symptoms and signs&lt;br /&gt;
**Hematuria&lt;br /&gt;
**mild proteinuria (&amp;lt;1–2 g/24 h)&lt;br /&gt;
***Sometimes nephrotic syndrome&lt;br /&gt;
**ESRD &lt;br /&gt;
**''Sensorineural hearing loss'' (60%)&lt;br /&gt;
***Early deafness suggest poor prognosis&lt;br /&gt;
**Bilateral anterior lenticonus, retinal flecks, recurrent corneal erosion&lt;br /&gt;
**Rare: mental retardation, leiomyomatosis, platelet defects &lt;br /&gt;
**Pathology&lt;br /&gt;
***EM: Thin GBM &amp;amp;rarr; multilamellations surrounding lucent areas that often contain granules of varying density (split basement membrane)&lt;br /&gt;
*Renal transplantation&lt;br /&gt;
**@@color(red):''~Anti-GBM antibodies'' directed toward the collagen epitopes absent in their native kidneys@@, but overt Goodpasture's syndrome is uncommon and graft survival is good&lt;/div&gt;</description>
			<pubDate>Wed, 14 Mar 2018 01:56:26 GMT</pubDate>			<dc:creator>Guhjy</dc:creator>			<comments>http://owiki.kmu.edu.tw/index.php/Talk:Alport%E2%80%99s_syndrome</comments>		</item>
	</channel>
</rss>